Canada Markets closed

PACB Jan 2024 25.000 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
8.300.00 (0.00%)
At close: 11:20AM EST
Full screen
Previous Close8.30
Open8.30
Bid8.50
Ask13.50
Strike25.00
Expire Date2024-01-19
Day's Range8.30 - 8.30
Contract RangeN/A
Volume10
Open Interest6
  • Zacks

    PacBio (PACB) Reports Impressive Preliminary Q4, FY21 Revenues

    PacBio's (PACB) solid fourth-quarter results are likely to have been boosted by strong segmental performances and robust placement of Sequel systems.

  • GlobeNewswire

    PacBio Grants Equity Incentive Award to New Employee

    MENLO PARK, Calif., Jan. 14, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 80,000 shares of PacBio common stock, and restricted stock units (“RSUs”) covering 40,000 shares of PacBio common stock, to a recently hired employee under the Pacific Biosciences 2020 Inducement Equity I

  • GlobeNewswire

    PacBio Names Lara Toerien as Vice President and General Manager for the Americas

    Industry Veteran Will Lead Company’s Commercial Growth Strategy in Americas RegionMENLO PARK, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate, sequencing platforms, welcomes Lara Toerien, Ph.D., as Vice President and General Manager for the company’s Americas region. Lara will be responsible for leading and developing PacBio’s commercial organization within North and South America while furthering its growth and market presenc